AT
Alloy Therapeutics, Inc.
SEC filingBiotechnology · Waltham, MA
Amount raised$30Msold at filing
Total offering$40M$10M still open
Investors in the raise11count reported to the SEC
FiledApr 15, 2026first sale Mar 31, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Anthony B. SunDirector
Alaa B. HalawaDirector
Ulrik B. NielsenDirector
Jason B. CammDirector
Jason ColomaDirector
Christian B. KanadyDirector
Alex B. KolicichDirector
Errik B. AndersonExecutive Officer, Director
Piotr B. BobrowiczExecutive Officer, Director
Logan B. SnyderDirector
Executive officers, directors and promoters as listed on the Form D.